Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands

被引:0
|
作者
Lomonte, C [1 ]
Cazzato, F [1 ]
Casucci, F [1 ]
Chimienti, D [1 ]
Bruno, A [1 ]
Cocola, S [1 ]
Verrelli, EA [1 ]
Basile, C [1 ]
机构
[1] Miulli Gen Hosp, Div Nephrol, Bari, Italy
关键词
female gender; hemodialysis; hyperparathyroidism; nodular hyperplasia; parathyroidectomy;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: An association between female gender and more aggressive patterns of secondary hyper-parathyroidisin (sHPTH) has been suggested: an increased incidence of refractory sHPTH seems evident in females; therefore, necessitating parathyroidectomy (PTx). Methods: This study aimed to verify the existence of such an association and secondly to evaluate the impact of female gender on parathyroid gland histology. Therefore, a retrospective study was conducted on 67 patients who underwent first PTx (either total or subtotal) in our hospital from 1999-2003. Out of these patients, we selected 55 (28 males, 27 females, mean age 50.8 +/- 14.7 SD yrs, dialysis duration 109.2 +/- 62.4 months) in whom all four parathyroid glands were identified and removed. Serum levels of immunoreactive intact parathyroid hormone (iPTH), alkaline phosphatase, calcium and phosphate were determined at the PTx time point. The same pathologist performed the histological studies of the parathyroid glands on seven serial sections of the glands. Gland hyperplasia was classified as (1) exclusively diffuse (EDH) when only diffuse hyperplasia was found in the four glands; (2) exclusively nodular (ENH) when only nodular hyperplasia was found in the four glands; (3) diffuse/nodular (D/NH), in which the four glands showed varying degrees of evolution towards both nodular and diffuse hyperplasia. Results: EDH was found in 13 patients with a prevalence of males (11/13; 84.6%); ENH was found in 23 patients with a prevalence of females (15/23; 65.2%); D/NH was found in 19 patients with a similar prevalence between females and males (10 females and 9 males). The difference in the male/female prevalence among the three groups was statistically significant (chi(2) test, p=0.015). Serum calcium was significantly higher in the ENH group (one-way analysis of variance, p=0.009). No difference was found among the three groups as far as age, dialysis duration, serum levels of iPTH, alkaline phosphatase and phosphate were concerned. Conclusions: Female gender is associated with more aggressive histological sHPTH patterns; this association seems to suggest that female gender predisposes to monoclonal proliferation of parathyroid glands in chronic uremia.
引用
收藏
页码:92 / 95
页数:4
相关论文
共 50 条
  • [1] Parathyroid glands hyperplasia and cardiovascular risk in hemodialysis patients
    Biassoli, Erika
    Petrucci, Ilaria
    Meola, Mario
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 241 - 241
  • [2] Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients
    Jaeger, Mark D.
    Serttas, Michaela
    Beneke, Jan
    Muller, Joerg A.
    Schrem, Harald
    Kaltenborn, Alexander
    Ramackers, Wolf
    Ringe, Bastian P.
    Gwiasda, Jill
    Traenkenschuh, Wolfgang
    Klempnauer, Juergen
    Scheumann, Georg F. W.
    PLOS ONE, 2017, 12 (10):
  • [3] A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia
    Basile, C
    Lomonte, C
    Vernaglione, L
    Casucci, F
    Chimienti, D
    Bruno, A
    Cocola, S
    Verrelli, EA
    Cazzato, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (04) : 968 - 974
  • [4] AUTONOMOUS NODULAR HYPERPLASIA OF PARATHYROID GLANDS
    ANDERSON, TJ
    BOYLE, IT
    JOURNAL OF PATHOLOGY, 1971, 105 (03): : 211 - &
  • [5] Can calcimimetics inhibit nodular hyperplasia of parathyroid glands?
    Fukagawa, Masafumi
    Taniguchi, Masatomo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (01) : 407 - 408
  • [6] Can calcimimetics inhibit nodular hyperplasia of parathyroid glands? Reply
    Drueke, Tilman B.
    Martin, David
    Rodriguez, Mariano
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (01) : 408 - 409
  • [7] Molecular patterns of diffuse and nodular parathyroid hyperplasia in long-term hemodialysis
    Tycova, Irena
    Sulkova, Sylvie Dusilova
    Stepankova, Jitka
    Krejcik, Zdenek
    Merkerova, Michaela Dostalova
    Stranecky, Viktor
    Hruba, Petra
    Girmanova, Eva
    Cernoch, Marek
    Lipar, Kvetoslav
    Marada, Tomas
    Povysil, Ctibor
    Viklicky, Ondrej
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2016, 311 (04): : E720 - E729
  • [8] DIFFERENTIAL-DIAGNOSIS OF ADENOMA OF PARATHYROID-GLANDS FROM THEIR NODULAR AND DIFFUSE HYPERPLASIA
    ASTAKHOV, AF
    SMIRNOV, VB
    ARKHIV PATOLOGII, 1983, 45 (06) : 52 - 60
  • [9] Hemodialysis Patients with Pruritus and Insomnia Have Increased Risk of Death
    Orasan, Olga Hilda
    Muresan, Flaviu
    Mot, Augustin
    Taut, Adela Sitar
    Minciuna, Iulia
    Coste, Sorina Cezara
    Negrean, Vasile
    Orasan, Remus Aurel
    Cozma, Angela
    BLOOD PURIFICATION, 2020, 49 (04) : 419 - 425
  • [10] VALUE OF SERUM ALKALINE-PHOSPHATASE IN EVALUATING HYPERPLASIA OF PARATHYROID-GLANDS IN CHRONIC-HEMODIALYSIS PATIENTS
    HUANG, YY
    HSU, BRS
    HUANG, BY
    HUANG, HS
    HUANG, MJ
    JOURNAL OF CLINICAL ULTRASOUND, 1994, 22 (03) : 193 - 197